2017
Aspirin for Primary Prevention
Richman IB, Owens DK. Aspirin for Primary Prevention. Medical Clinics Of North America 2017, 101: 713-724. PMID: 28577622, DOI: 10.1016/j.mcna.2017.03.004.BooksMeSH KeywordsAge FactorsAspirinCardiovascular DiseasesColorectal NeoplasmsDiabetes MellitusGastrointestinal HemorrhageHumansHypertensionLipidsMyocardial InfarctionPlatelet Aggregation InhibitorsPractice Guidelines as TopicPrimary PreventionRacial GroupsRisk AssessmentRisk FactorsSex FactorsSmokingStrokeConceptsColorectal cancerPrimary preventionCardiovascular diseaseUS Preventive Services Task ForceNonfatal myocardial infarctionCardiovascular disease riskAdults age 50Intracranial bleedingOlder patientsMyocardial infarctionSelect populationAge 50AspirinAdults 60Disease riskAvailable evidenceRiskCancerDiseasePreventionTask ForceBleedingInfarctionPatientsStroke
2016
Cost-effectiveness of Intensive Blood Pressure Management
Richman IB, Fairley M, Jørgensen ME, Schuler A, Owens DK, Goldhaber-Fiebert JD. Cost-effectiveness of Intensive Blood Pressure Management. JAMA Cardiology 2016, 1: 872-879. PMID: 27627731, PMCID: PMC5892423, DOI: 10.1001/jamacardio.2016.3517.Peer-Reviewed Original ResearchConceptsIntensive blood pressure managementSystolic Blood Pressure Intervention TrialBlood pressure managementAdverse event ratesStandard managementPressure managementAdverse eventsPopulation-based observational dataSystolic blood pressure goalEvent ratesHigher adverse event ratesBlood pressure goalsSerious adverse eventsHigh-risk patientsHigh-risk adultsSystolic blood pressureNational Inpatient SampleTreatment of hypertensionCause-specific mortalityLifetime costsMarkov cohort modelCost-effectiveness analysisCardiovascular morbidityBlood pressureHeart failure